Docetaxel in non-small cell lung cancer

Author： Souquet Pierre-Jean   Geriniere Laurence  

Publisher： Future Medicine

ISSN： 1475-0708

Source： Therapy, Vol.3, Iss.5, 2006-09, pp. : 579-590

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Docetaxel as a Single Agent in First-Line Therapy of Non-Small Cell Lung Cancer

By  

Oncology Research and Treatment, Vol. 23, Iss. 6, 2004-11 ,pp. : 16-17

Karger

Access to resources Recommend Favorite

A Pilot Study of Docetaxel and Trofosfamide as Second-Line ‘Metronomic’ Chemotherapy in the Treatment of Metastatic Non-Small Cell Lung Cancer (NSCLC)

By  

Oncology Research and Treatment, Vol. 31, Iss. 4, 2008-03 ,pp. : 185-189

Karger

Access to resources Recommend Favorite

Ifosfamide in Non-Small Cell Lung Cancer

By  

Oncology, Vol. 65, Iss. 2, 2003-11 ,pp. : 50-54

Karger

Access to resources Recommend Favorite

The Influence of Sex in Non-Small Cell Lung Cancer

By  

Oncology Research and Treatment, Vol. 32, Iss. 10, 2009-09 ,pp. : 547-548

Karger

Access to resources Recommend Favorite

Gallbladder Metastasis of Non-Small Cell Lung Cancer

By  

Oncology Research and Treatment, Vol. 27, Iss. 4, 2004-09 ,pp. : 398-400

Karger

Access to resources Recommend Favorite